To determine whether receiving melanoma genetic test results undermines
perceived control over melanoma prevention, control-related beliefs were
examined among 60 adults from melanoma-prone families receiving
CDKN2A/p16 test results (27 unaffected noncarriers, 15
unaffected carriers, 18 affected carriers; response rate at 2
years=64.9% of eligible respondents). Multilevel modeling of
perceived control ratings over a 2-year period revealed significant variation in
individual trajectories: most participants showed increases (45%) or no
change (38.3%), while 16.7% showed decreases. At the group
level, noncarriers reported sustained increases through the 2-year follow-up
(ps<.05); unaffected carriers reported significant
short-term increases (ps<.05); and affected carriers
reported no change. Participants in all groups continued to rate photoprotection
as highly effective in reducing melanoma risk and reported decreased belief that
carrying the p16 mutation would inevitably lead to the
development of melanoma. Qualitative responses immediately following counseling
and test reporting corroborated these findings, as 93% indicated it was
possible to either prevent (64.9%) or decrease the likelihood
(28.1%) of future melanomas. Thus, genetic test reporting does not
generally undermine perceived control over melanoma prevention, though
variability in response to positive results warrants future study.